Immunexpress.com

SEATTLE, Oct. 22, 2015 – Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients, today announced the  appointment of Roy F. J. Davis, Ph.D., M.D., M.H.A., as Chief Medical Officer. “Dr. Davis has over 30 years of experience providing and directing patient care for multiple healthcare-provider organizations,” said Roslyn Brandon,…

Read More